MeSH term | MeSH ID | Detail |
---|---|---|
Uveitis, Intermediate | D015867 | 3 associated lipids |
Venous Thrombosis | D020246 | 11 associated lipids |
C24 GlcCer is a lipid of Sphingolipids (SP) class. The related experimental models are Knock-out.
To understand associated biological information of C24 GlcCer, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
There are no associated biomedical information in the current reference collection.
We collected disease MeSH terms mapped to the references associated with C24 GlcCer
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
There are no associated biomedical information in the current reference collection.
Knock-out are used in the study 'Rho/ROCK pathway is essential to the expansion, differentiation, and morphological rearrangements of human neural stem/progenitor cells induced by lysophosphatidic acid.' (Frisca F et al., 2013).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Adar T et al. | Aggregation of red blood cells in patients with Gaucher disease. | 2006 | Br. J. Haematol. | pmid:16827817 |
Hollak CE et al. | [From gene to disease; Gaucher disease]. | 2005 | Ned Tijdschr Geneeskd | pmid:16223076 |
Deguchi H et al. | Decreased plasma sensitivity to activated protein C by oral contraceptives is associated with decreases in plasma glucosylceramide. | 2005 | J. Thromb. Haemost. | pmid:15869587 |
Harzer K et al. | Concurrent increase of cholesterol, sphingomyelin and glucosylceramide in the spleen from non-neurologic Niemann-Pick type C patients but also patients possibly affected with other lipid trafficking disorders. | 2003 | FEBS Lett. | pmid:12606053 |
Mariani G et al. | Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi. | 2003 | J. Nucl. Med. | pmid:12902415 |
Campbell PE et al. | A model of neuronopathic Gaucher disease. | 2003 | J. Inherit. Metab. Dis. | pmid:14707511 |
Poll LW et al. | Response of Gaucher bone disease to enzyme replacement therapy. | 2002 | Br J Radiol | pmid:12036830 |
Schaison G et al. | [French results of enzyme replacement therapy in Gaucher's disease]. | 2002 | Bull. Acad. Natl. Med. | pmid:12412377 |
Stirnemann J and Belmatoug N | [Adult Gaucher disease]. | 2001 | Rev Med Interne | pmid:11794882 |
Liu Y et al. | Mice with type 2 and 3 Gaucher disease point mutations generated by a single insertion mutagenesis procedure. | 1998 | Proc. Natl. Acad. Sci. U.S.A. | pmid:9482915 |